CD274 and urinary bladder carcinoma: Longitudinal studies assessing the clinical outcomes and therapeutic responses associated with cytoinclusion-based PD-L1 expression profiling are also needed to elucidate its potential role in guiding personalized treatment strategies and improving patient outcomes in bladder cancer.